COMPANY
Sight Sciences
FDA-cleared device company Clinical Phase 3
Timeline
- Trial start Not phased (device or behavioral study): TearCare MGX™ System With and Without Warming Hold source ↗
- Trial start Not phased (device or behavioral study): OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma source ↗
- Trial start Not phased (device or behavioral study): A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX) source ↗
- Trial start Phase 4: A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma source ↗
- Trial start Not phased (device or behavioral study): Study of OMNI Surgical System and iStent for Eyes With OAG (Trident) source ↗
- Trial start —: A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System source ↗
- Trial start —: An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0) source ↗
- Trial start Not phased (device or behavioral study): Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA) source ↗
- Trial start Not phased (device or behavioral study): A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma source ↗
- Trial start Not phased (device or behavioral study): A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma source ↗
- Trial start Not phased (device or behavioral study): Study of OMNI System in OAG (GEMINI) source ↗
- Trial start Not phased (device or behavioral study): TearCare System to Treat Dry Eye Disease source ↗
- Trial start Not phased (device or behavioral study): Pilot Study of TearCare System - Long-Term Extension source ↗
- Trial start Not phased (device or behavioral study): Study of the TearCare System in Dry Eye Disease source ↗
- Trial start Not phased (device or behavioral study): Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease source ↗
- Trial start Not phased (device or behavioral study): Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma source ↗
- Trial start Not phased (device or behavioral study): A Pilot Study of the TearCare System in Adults With Dry Eye Disease source ↗
Clinical trials (lead sponsor) 17
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06948773 | A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX) | Not phased (device or behavioral study) | Active, not recruiting | May 21, 2025 | Sep 30, 2026 (estimated) |
| NCT07365735 | TearCare MGX™ System With and Without Warming Hold | Not phased (device or behavioral study) | Completed | Mar 17, 2026 | May 19, 2026 (actual) |
| NCT06991270 | OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma | Not phased (device or behavioral study) | Recruiting | 2026-02 | Aug 31, 2026 (estimated) |
| NCT04795752 | Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA) | Not phased (device or behavioral study) | Completed | Apr 28, 2021 | Sep 23, 2024 (actual) |
| NCT02928289 | Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma | Not phased (device or behavioral study) | Terminated | Jan 23, 2017 | Jan 17, 2019 (actual) |
| NCT03804502 | Pilot Study of TearCare System - Long-Term Extension | Not phased (device or behavioral study) | Completed | Dec 17, 2018 | May 21, 2019 (actual) |
| NCT04658095 | Study of OMNI Surgical System and iStent for Eyes With OAG (Trident) | Not phased (device or behavioral study) | Terminated | Jan 11, 2022 | Nov 18, 2022 (actual) |
| NCT03006978 | A Pilot Study of the TearCare System in Adults With Dry Eye Disease | Not phased (device or behavioral study) | Completed | 2017-01 | 2017-02 (actual) |
| NCT03857919 | TearCare System to Treat Dry Eye Disease | Not phased (device or behavioral study) | Completed | Mar 3, 2019 | Feb 17, 2020 (actual) |
| NCT03502447 | Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease | Not phased (device or behavioral study) | Terminated | Apr 20, 2018 | Dec 4, 2018 (actual) |
| NCT03588624 | Study of the TearCare System in Dry Eye Disease | Not phased (device or behavioral study) | Completed | Jul 12, 2018 | Oct 11, 2018 (actual) |
| NCT04872348 | An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0) | Not listed | Completed | Jul 1, 2021 | Nov 2, 2023 (actual) |
| NCT06407973 | A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma | Phase 4 | Terminated | Aug 21, 2024 | Jan 20, 2025 (actual) |
| NCT05044793 | A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System | Not listed | Completed | Sep 1, 2021 | Aug 21, 2023 (actual) |
| NCT03861169 | Study of OMNI System in OAG (GEMINI) | Not phased (device or behavioral study) | Completed | Mar 11, 2019 | May 4, 2021 (actual) |
| NCT04616573 | A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma | Not phased (device or behavioral study) | Terminated | Nov 13, 2020 | Jan 20, 2021 (actual) |
| NCT04465630 | A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma | Not phased (device or behavioral study) | Terminated | Jun 19, 2020 | Mar 2, 2021 (actual) |